Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online December 4, 2018.
Article Versions
- previous version (September 19, 2018 - 09:44).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2018
Author Information
- Jennifer Johns1,
- Paolo Golfetto2,
- Tia Bush3,
- Gianmaurizio Fantozzi2,
- John Shabushnig4,*,
- Anthony Perry5,
- Fran Degrazio6,
- Dorothee Streich7,
- Jahanvi Miller8,
- Herve Soukiassian9,
- Amy Stanton10 and
- Rick Watson11
- 1Pfizer, Inc, N. Peapack, NJ, USA;
- 2Stevenato Group, Via Molinella, Padua, Italy;
- 3Amgen Inc., West Greenwich, RI, USA;
- 4Insight Pharma Consulting, LLC, Marshall, MI, USA;
- 5Schott North America, Inc., Lebanon, PA, USA;
- 6West Pharmaceutical Services, Inc., Exton, PA, USA;
- 7Bayer AG, Kaiser-Wilhelm-Allee, Leverkusen, Germany;
- 8Parenteral Drug Association, Bethesda, MD, USA;
- 9Becton Dickinson, Le Pont-de-Claix, France;
- 10Amgen Inc., Thousand Oaks, CA, USA;
- 11Merck & Co., West Point, PA, USA
- ↵* Corresponding Author: e-mail: johnshabushnig{at}aol.com
Cited By...
Jump to section
Related Articles
Cited By...
- A Proof-of-Concept Study on a Universal Standard Kit to Evaluate the Risks of Inspectors for Their Foundational Ability of Visual Inspection of Injectable Drug Products
- Development and Qualification of Visible Particle Load Analysis Methods for Injectable Drug Product Primary Packaging Components
- Points to Consider: Best Practices to Identify Particle Entry Routes along the Manufacturing Process for Parenteral Formulations